What is the intravenous dose and schedule of durvalumab in the GCD regimen?
Label:chem
Topic
Durvalumab (anti-PD-L1 monoclonal antibody) is the immunotherapy component of the regimen.
Answer
Durvalumab 1 500 mg IV on Day 1 of each 21-day cycle (up to eight cycles) and then 1 500 mg IV every 4 weeks as monotherapy until progression or unacceptable toxicity.
Return to Home
Chemical List
Knowledge you may be interested in